PL2739266T3 - Trwałe przeciwzapalne roztwory do wstrzyknięcia - Google Patents

Trwałe przeciwzapalne roztwory do wstrzyknięcia

Info

Publication number
PL2739266T3
PL2739266T3 PL12819309T PL12819309T PL2739266T3 PL 2739266 T3 PL2739266 T3 PL 2739266T3 PL 12819309 T PL12819309 T PL 12819309T PL 12819309 T PL12819309 T PL 12819309T PL 2739266 T3 PL2739266 T3 PL 2739266T3
Authority
PL
Poland
Prior art keywords
injection
stable anti
inflammatory
inflammatory solutions
solutions
Prior art date
Application number
PL12819309T
Other languages
English (en)
Inventor
Gregory A. Demopulos
Wayne R. Gombotz
Hui-Rong Shen
Original Assignee
Omeros Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47627326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2739266(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omeros Corporation filed Critical Omeros Corporation
Publication of PL2739266T3 publication Critical patent/PL2739266T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PL12819309T 2011-08-04 2012-08-03 Trwałe przeciwzapalne roztwory do wstrzyknięcia PL2739266T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161515234P 2011-08-04 2011-08-04
EP12819309.1A EP2739266B1 (en) 2011-08-04 2012-08-03 Stable anti-inflammatory solutions for injection

Publications (1)

Publication Number Publication Date
PL2739266T3 true PL2739266T3 (pl) 2017-07-31

Family

ID=47627326

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12819309T PL2739266T3 (pl) 2011-08-04 2012-08-03 Trwałe przeciwzapalne roztwory do wstrzyknięcia

Country Status (20)

Country Link
US (3) US20130035362A1 (pl)
EP (1) EP2739266B1 (pl)
JP (2) JP6174579B2 (pl)
KR (1) KR101951064B1 (pl)
CN (1) CN103957886B (pl)
AR (1) AR089203A1 (pl)
AU (1) AU2012289968B2 (pl)
BR (1) BR112014002631B1 (pl)
CA (1) CA2844152C (pl)
CL (1) CL2014000267A1 (pl)
DK (1) DK2739266T3 (pl)
ES (1) ES2600153T3 (pl)
IL (1) IL230779B (pl)
MX (1) MX347373B (pl)
NZ (1) NZ621484A (pl)
PL (1) PL2739266T3 (pl)
PT (1) PT2739266T (pl)
RU (1) RU2635521C2 (pl)
WO (1) WO2013020021A1 (pl)
ZA (1) ZA201401344B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202400324T1 (it) 2013-03-15 2024-11-15 Tonix Pharma Ltd Formulazioni eutettiche di ciclobenzaprina cloridrato e mannitolo
US10646574B2 (en) * 2014-07-21 2020-05-12 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US20170049134A1 (en) * 2015-08-18 2017-02-23 Empire Technology Development Llc Meat tendering using food grade natural products for reducing muscle contraction
US20220347122A1 (en) 2019-03-15 2022-11-03 Ftf Pharma Private Limited Solutions for oral dosage
FR3108841B1 (fr) 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
FR3123563B1 (fr) * 2021-06-03 2025-02-14 Algotherapeutix Utilisation de l’amitriptyline et/ou l’un de ses sels pharmaceutiquement acceptable comme agent conservateur
CN116165306B (zh) * 2023-04-25 2023-11-17 湖南九典制药股份有限公司 酮洛芬凝胶贴膏中有关物质的分析测定方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
IT1269583B (it) * 1994-04-26 1997-04-08 Bayer Italia Spa Preparazioni farmaceutiche a base di una soluzione di ketoprofene in capsule di gelatina molle e metodo per la loro produzione
WO1996019233A2 (en) * 1994-12-12 1996-06-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
US7091181B2 (en) * 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
KR100517210B1 (ko) 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
US7973068B2 (en) * 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7022740B2 (en) * 2004-04-29 2006-04-04 Leonard Mackles Lubricious ophthalmic solutions
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
MX2007014496A (es) * 2005-05-20 2008-02-11 Omeros Corp Composiciones de inhibidor de ciclooxigenasa y antagonista de los canales de calcio y metodos para usarlas en procedimientos urologicos.
CA2644311C (en) * 2006-03-01 2012-07-10 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
US8784893B2 (en) 2007-02-05 2014-07-22 Carbylan Therapeutics, Inc. Polymer formulations for delivery of bioactive agents
WO2008115572A1 (en) * 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
JP6225030B2 (ja) * 2011-02-15 2017-11-01 アラーガン、インコーポレイテッドAllergan,Incorporated 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物

Also Published As

Publication number Publication date
BR112014002631B1 (pt) 2022-04-19
AR089203A1 (es) 2014-08-06
CN103957886B (zh) 2016-03-30
EP2739266A1 (en) 2014-06-11
WO2013020021A1 (en) 2013-02-07
EP2739266A4 (en) 2014-12-31
BR112014002631A2 (pt) 2017-03-07
AU2012289968A1 (en) 2013-03-28
IL230779B (en) 2019-05-30
IL230779A0 (en) 2014-03-31
US20160166696A1 (en) 2016-06-16
US20130035362A1 (en) 2013-02-07
ES2600153T3 (es) 2017-02-07
PT2739266T (pt) 2016-10-04
NZ621484A (en) 2016-05-27
JP6174579B2 (ja) 2017-08-02
KR20140057579A (ko) 2014-05-13
CA2844152A1 (en) 2013-02-07
EP2739266B1 (en) 2016-07-27
RU2014108159A (ru) 2015-09-10
CL2014000267A1 (es) 2014-08-29
DK2739266T3 (en) 2016-10-03
AU2012289968B2 (en) 2014-01-16
KR101951064B1 (ko) 2019-02-21
RU2635521C2 (ru) 2017-11-13
HK1198911A1 (en) 2015-06-19
JP2014521694A (ja) 2014-08-28
US20180344855A1 (en) 2018-12-06
MX2014001368A (es) 2014-06-11
CN103957886A (zh) 2014-07-30
ZA201401344B (en) 2016-10-26
MX347373B (es) 2017-04-25
CA2844152C (en) 2020-04-14
JP2017014288A (ja) 2017-01-19

Similar Documents

Publication Publication Date Title
EP2667915A4 (en) INJEKTOR
DK2685832T3 (da) Stabiliserede hypohalogensyreopløsninger
DK2902058T3 (da) Injektionsanordning
EP2673344A4 (en) STABLE BIO OIL
BR112014002399A2 (pt) conjunto
DK3184136T3 (da) Injektor
EP2692380A4 (en) SYRINGE
DK2775557T3 (da) Brændselscelle
EP2709645A4 (en) ENHANCED PEPTIDE PHARMACEUTICAL AGENTS
BR112013025868A2 (pt) dispositivo de injeção
CO6870021A2 (es) Conjunto dispensador
FI20115126L (fi) Polttoaineen ruiskutusjärjestelmä
IL230779B (en) Stable anti-inflammatory solutions for injection
BR112013031339A2 (pt) dispositivo de injeção
EP2620175A4 (en) INJEKTOR
EP2757623A4 (en) FUEL CELL
DE112011105455T8 (de) Brennstoffzelle
EP2699671A4 (en) INFLAMMATORY ACTIVE SUBSTANCES
EP2768053A4 (en) FUEL CELL
EP2749597A4 (en) Injection molding
EP2722040A4 (en) Lidocaine-containing cataplasm
IL228573A0 (en) Otamixaban formulations with improved stability
EP2696415A4 (en) FUEL CELL
FI20115649A0 (fi) Polttoaineen ruiskutusjärjestelmä
IT1403977B1 (it) Lunetta